These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37098851)

  • 1. Associations between four polymorphisms of the SLCO1B1 and effectiveness of the statins: a meta-analysis.
    Nguyen HH; Nguyen CTT; Mai TNP; Huong PT
    Pharmacogenet Genomics; 2023 Jun; 33(4):65-78. PubMed ID: 37098851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly.
    Akao H; Polisecki E; Kajinami K; Trompet S; Robertson M; Ford I; Jukema JW; de Craen AJ; Westendorp RG; Shepherd J; Packard C; Buckley BM; Schaefer EJ
    Atherosclerosis; 2012 Feb; 220(2):413-7. PubMed ID: 22189199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals.
    Prado Y; Saavedra N; Zambrano T; Lagos J; Rosales A; Salazar LA
    Int J Mol Sci; 2015 Aug; 16(9):20609-19. PubMed ID: 26334272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between SLCO1B1 polymorphisms and lipid-lowering response to simvastatin therapy in Thai hypercholesterolaemic patients.
    Kaewboonlert N; Thitisopee W; Sirintronsopon W; Porntadavity S; Jeenduang N
    J Clin Pharm Ther; 2018 Oct; 43(5):647-655. PubMed ID: 29575099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population.
    Giannakopoulou E; Ragia G; Kolovou V; Tavridou A; Tselepis AD; Elisaf M; Kolovou G; Manolopoulos VG
    Mol Biol Rep; 2014 Jul; 41(7):4631-8. PubMed ID: 24668570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between SLCO1B1 polymorphism and the lipid-lowering effects of atorvastatin and simvastatin in Chinese individuals.
    Fu Q; Li YP; Gao Y; Yang SH; Lu PQ; Jia M; Zhang LR
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1269-74. PubMed ID: 23263738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-Analysis of the SLCO1B1 c.521T>C Variant Reveals Slight Influence on the Lipid-Lowering Efficacy of Statins.
    Dou Y; Zhu X; Wang Q; Tian X; Cheng J; Zhang E
    Ann Lab Med; 2015 May; 35(3):329-35. PubMed ID: 25932441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between SLCO1B1 521 T＞C and 388 A＞G Polymorphisms and Statins Effectiveness: A Meta-Analysis.
    Dai R; Feng J; Wang Y; Yang Y; Deng C; Tang X; Zhao Y; Zhou H; Zhang F
    J Atheroscler Thromb; 2015 Aug; 22(8):796-815. PubMed ID: 25832498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLCO1B1 variants and statin-induced myopathy--a genomewide study.
    ; Link E; Parish S; Armitage J; Bowman L; Heath S; Matsuda F; Gut I; Lathrop M; Collins R
    N Engl J Med; 2008 Aug; 359(8):789-99. PubMed ID: 18650507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians.
    Sortica VA; Fiegenbaum M; Lima LO; Van der Sand CR; Van der Sand LC; Ferreira ME; Pires RC; Hutz MH
    Clin Chem Lab Med; 2012 Mar; 50(3):441-8. PubMed ID: 22505549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible gene-gender interaction between the SLCO1B1 polymorphism and statin treatment efficacy.
    Hubacek JA; Dlouha D; Adámkova V; Lanska V; Ceska R; Vrablik M
    Neuro Endocrinol Lett; 2012; 33 Suppl 2():22-5. PubMed ID: 23183505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLCO1B1 Gene Polymorphisms (rs2306283 and rs4149056) and Statin-Induced Myopathy in Jordanian Diabetics.
    Shahrure ZM; Irshaid YM; Mustafa KN; Abujbara MA; Al Shhab M; El-Khateeb MS; Ajlouni KM
    Curr Rev Clin Exp Pharmacol; 2021; 16(3):281-288. PubMed ID: 32860365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lipid-lowering efficacy of rosuvastatin is associated with variations in SLCO1B1: a 12-month prospective cohort study.
    Zakria M; Hussain A; Ahmad N; Ahmed N; Rauf MA; Siraj S
    Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4708-4717. PubMed ID: 37259755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLCO1B1 genetic variants, long-term low-density lipoprotein cholesterol levels and clinical events in patients following cardiac catheterization.
    Li JH; Suchindran S; Shah SH; Kraus WE; Ginsburg GS; Voora D
    Pharmacogenomics; 2015; 16(5):449-58. PubMed ID: 25916517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of SLCO1B1 Polymorphisms and Atorvastatin Safety and Efficacy: A Meta-analysis.
    Du Y; Wang S; Chen Z; Sun S; Zhao Z; Li X
    Curr Pharm Des; 2018; 24(34):4044-4050. PubMed ID: 30569848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population.
    Wu H; Huang Q; Yu Z; Wu H; Zhong Z
    Lipids Health Dis; 2020 Sep; 19(1):202. PubMed ID: 32891149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of protective haplotypes of the
    Favela-Mendoza AF; Rodríguez-Rodríguez BG; Rojas-Prado E; Chávez-Arreguin M; Aguilar-Velázquez JA; Martínez-Cortés G; Rangel-Villalobos H
    Per Med; 2021 Sep; 18(6):533-540. PubMed ID: 34674552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin-induced myopathy SLCO1B1 521T > C is associated with prediabetes, high body mass index and normal lipid profile in Emirati population.
    Saber-Ayad M; Manzoor S; El-Serafi A; Mahmoud I; Abusnana S; Sulaiman N
    Diabetes Res Clin Pract; 2018 May; 139():272-277. PubMed ID: 29534995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASSOCIATION OF SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B1 GENE POLYMORPHISM WITH RESPONSE TO ATORVASTATIN AND ASSOCIATED MYOPATHY IN IRAQI DYSLIPIDEMIA PATIENTS.
    Dheyaa Aziz N; Abbood SH; Al-Mayali AH; Hadi NR
    Pol Merkur Lekarski; 2023; 51(5):496-503. PubMed ID: 38069850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of
    Mladenovska K; Grapci AD; Vavlukis M; Kapedanovska A; Eftimov A; Geshkovska NM; Nebija D; Dimovski AJ
    Pharmazie; 2017 May; 72(5):288-295. PubMed ID: 29441875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.